|
|
|
|
Science Sparks @ ACTREC
|
 15 June 2026 |
Vol. No. 15 ; Issue No.739 |
|
|
Publications
|
|
1. Maniar J, Dhas P, Datt P, Dange P, Gandhi KA, Bhatia D, Chaubal R, Gardi N, Kembhavi Y, Joshi S, Badwe R, Gupta S. Hypoxia-reoxygenation cycle leads to context dependent phenotypic effects in breast cancer cell lines. Molecular Biology Reports.;53(1):931.
2. Sharma A, Garale M, Lila A, Chakrabarty N, Badhe P, Patil V, Thakkar H, Memon S, Pantvaidya G, Bal M, Barnabas R, Karlekar M, Pai T, Sathe P, Fernandes G, Bandgar T (2026). Diagnostic Performance of Parathyroid CT and CT-Guided Targeted Parathyroidectomy in MEN1-Associated Primary Hyperparathyroidism, Annals of Endocrinology.
3. Shivshankar S, Mhamane S, Patil PS, Deodhar K, Budukh AM (2026). The changing landscape of gastrointestinal cancers in India: An analysis involving published data from Cancer Incidence in Five Continents of 2013-2017 compared to 1988-1992. Indian Journal of Gastroenterology.
4. Redhu AK, Gadewal N, Gota V (2026). Targeting IDH1 (R132H)-Driven Oncometabolic Vulnerabilities: Structure-Guided Discovery of Phytochemical Inhibitor. In Silico Research in Biomedicine
5. Raveendran V, Sinha S, Mukherjee P, Kumar A, Shinde PH, Prabu AC, Punde RN, Chaudhari LN, Mathew SM, Mohanty S, Swain M, Budrukkar A, Ghosh Laskar S(2026) Exploring the need for plan adaptation in robustly optimized head and neck intensity modulated proton therapy: A dosimetric perspective from initial institutional experience. Clinical Oncology.
Patent
ACTREC (2026). An Electrosurgical Instrument for En-Bloc Resection of Bladder Tumors. Design Number:496072-001.The Patent Office Government of India.
|
|
|
|
|
Interesting Reads
|
|
Menendez-Montes I, Marin-Vicente C, Mukherjee S, Ahmed MS, Gomez MJ, Anene-Nzelu CG, Lee CJM, Koslowski S, Solmonson A, Tassin T, Ali SR, Pessoa P, Elnwasany A, Lam NT, Thet S, Calvo E, Cardoso AC, Pereira AHM, Xiao F, Wang P, Mohamed A, El-Feky H, Elghamry A, Gancedo-Alonso G, Nguyen NUN, Hsu CC, Westfall AK, DeBerardinis R, Foo RS, Kinter M, Pressé S, Xing C, Szweda L, Aroumougame A, Sanchez-Cabo F, Enriquez JA, Torres M, Vazquez J, Sadek HA (2026). Mitochondria directly interact with the nuclear pore complex. Nature.
|
|
|
Video of the Week
|
|
| Immunotherapy for Lynch Syndrome Associated Cancers |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1997, FDA approved Rituxan (rituximab), the first monoclonal antibody, to treat non-Hodgkin’s lymphoma.
|
|
|
|
Cancer News
|
| |
|
UCLA-led research suggests early heart changes may predict future cancer risk.
|
|
Eurekalert, 11/06/2026
|
|
The researchers assessed baseline cardiac structure and function using cardiac MRI imaging at enrollment and participants were followed for cancer incidence over an average of 18 years. They also used multivariable statistical models to investigate the association of cardiac MRI measurements...
|
| |
|
First CD123-targeted ADC secures FDA approval for rare blood cancer
|
|
Nature, 11/06/2026
|
|
The FDA approved pivekimab sunirine in this setting on the basis of a phase I/II trial of the ADC in 84 adults with frontline or relapsed/refractory BPDCN. In 33 patients with treatment-naive BPDCN, 23 (70%) achieved a complete response or clinical complete remission (CR/CRc),....
|
|
|
|
|
| |
|
|
|
Scientists shut down cancer DNA repair to overcome drug resistance
|
|
Sciencedaily, 10/06/2026
|
|
Cancer cells often survive treatment by fixing the DNA damage that therapy is meant to cause. Researchers found that UNI418 can disrupt this repair ability, leaving cancer cells more exposed. When combined with a PARP inhibitor, it helped resistant cancer cells respond to treatment again...
|
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
